CS
VANI icon

Credit Suisse’s Vivani Medical VANI Stock Holding History

Credit Suisse’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-555
Closed -$16K – 3960
2017
Q1 		$16K Buy
555
+75
+16% +$2.87K ﹤0.01% 3772
2016
Q4 		$22K Buy
+480
New +$27.4K ﹤0.01% 4060
2016
Q3 		– Sell
-1,856
Closed -$159K – 4267
2016
Q2 		$159K Buy
1,856
+1,169
+170% +$122K ﹤0.01% 3946
2016
Q1 		$80K Sell
687
-679
-50% -$78.1K ﹤0.01% 3856
2015
Q4 		$193K Sell
1,366
-692
-34% -$101K ﹤0.01% 3906
2015
Q3 		$293K Buy
2,058
+1,239
+151% +$344K ﹤0.01% 3728
2015
Q2 		$268K Buy
+819
New +$263K ﹤0.01% 4072

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CD
Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Credit Suisse's VANI Position: Q2 2017 in Review

Credit Suisse sold out of Vivani Medical (VANI) in Q2 2017, closing a stake of 555 shares — an estimated $16K sold.

Credit Suisse first reported a position in VANI in Q2 2015 and held it in 7 quarters. The position peaked at $293K in Q3 2015. 44 funds tracked by Wall St. Rank hold VANI as of Q2 2017.

  • Credit Suisse reported no remaining Vivani Medical position as of Q2 2017 after selling out during the quarter.
  • Credit Suisse sold 555 Vivani Medical shares in Q2 2017, an estimated $16K.
  • Credit Suisse first reported a position in Vivani Medical in Q2 2015 and held it in 7 quarters.
  • Credit Suisse's Vivani Medical position peaked at $293K in Q3 2015.
  • 44 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2017.

Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.